A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS

NCT00001017 ·Status: COMPLETED ·Phase: PHASE3

A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis

NCT00000639 ·Status: COMPLETED ·Phase: NA

Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

NCT00002040 ·Status: COMPLETED ·Phase: NA

Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

NCT00002076 ·Status: COMPLETED ·Phase: NA

An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

NCT00002077 ·Status: COMPLETED ·Phase: NA

A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.

NCT00002113 ·Status: COMPLETED ·Phase: NA

High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals

NCT00885703 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Platform Trial For Cryptococcal Meningitis

NCT06666322 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

NCT00145249 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome

NCT00002019 ·Status: COMPLETED ·Phase: NA

Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis

NCT04532463 ·Status: COMPLETED

Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis

NCT00002010 ·Status: COMPLETED ·Phase: NA

Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)

NCT04031833 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS

NCT00002294 ·Status: COMPLETED ·Phase: NA

Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy

NCT00002038 ·Status: COMPLETED ·Phase: NA

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

NCT00002277 ·Status: COMPLETED ·Phase: PHASE3

Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis

NCT06414512 ·Status: COMPLETED ·Phase: PHASE2

Amphotericin B for Non-HIV Cryptococcal Meningitis Patients

NCT06178627 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis

NCT05471063 ·Status: UNKNOWN ·Phase: NA

Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection

NCT01562132 ·Status: TERMINATED ·Phase: PHASE2

Three Induction Treatments on Cryptococcal Meningitis

NCT04072640 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis

NCT02136030 ·Status: UNKNOWN ·Phase: NA

Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia

NCT03945448 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common

NCT00002325 ·Status: COMPLETED ·Phase: NA

Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa

NCT01715922 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3